Irvine, CA, United States of America

Jeffrey L Edelman

USPTO Granted Patents = 22 


 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 167(Granted Patents)


Location History:

  • Newport Beach, CA (US) (2011)
  • Irvine, CA (US) (2010 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey L. Edelman in Ophthalmic and Pharmaceutical Technology

Introduction: Jeffrey L. Edelman, based in Irvine, CA, is a prominent inventor with a remarkable portfolio of 22 patents. His work primarily focuses on advancements in ophthalmic treatments and pharmaceutical compositions. With a deep commitment to innovation, Edelman has made significant contributions to the field, particularly through his association with Allergan, Inc.

Latest Patents: Among his latest innovations, Edelman has developed biodegradable intravitreal tyrosine kinase implants. These biocompatible intraocular implants are designed to deliver a tyrosine kinase inhibitor effectively into the vitreous of the eye over an extended period. The implants aim to treat or reduce the occurrence of various ocular conditions, offering new therapeutic options for patients.

Another notable patent pertains to novel 4-pregenen-11β-17-21-triol-3,20-dione derivatives. This invention describes processes for preparing these compounds, along with their use as pharmaceutical agents, modulating glucocorticoid or mineralocorticoid receptors. The significance of this work lies in its potential to address disorders associated with receptor modulation, broadening treatment avenues in the pharmaceutical industry.

Career Highlights: Jeffrey L. Edelman has built a notable career at Allergan, Inc., where his innovative spirit has led to advancements in drug delivery systems and pharmaceuticals. His research reflects a commitment to resolving complex medical challenges through inventive solutions, enhancing patient care and treatment efficacy.

Collaborations: Throughout his career, Edelman has collaborated with esteemed colleagues such as Thomas C. Malone and Patrick Michael Hughes. These partnerships exemplify the collaborative nature of innovation in medicine, fostering a rich environment for research and development.

Conclusion: Jeffrey L. Edelman’s contributions to the fields of ophthalmology and pharmacology underscore his role as a leading inventor. With a strong portfolio of patents and a collaborative spirit, he continues to influence advancements in medical technology, paving the way for innovative solutions that enhance patient outcomes. His work at Allergan, Inc. embodies the essence of innovation through dedicated research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…